PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for August 3, 2004 Subscribe to this News Feed    
 

New Millenium Signal Processing Algorithms for Stethoscope Heart Auscultation

Biosignetics Announces First Release of BSignal Heart Energy Processing Software

(PRWEB) August 3, 2004 -- Heart disease is the leading cause of death in the United States. It affects men and women of every age and race. More than 64 million Americans suffer from one or more forms of cardiovascular disease, including high blood pressure, coronary heart disease, congestive heart failure, stroke, and congenital heart defects", indicated President G.W. Bush in his proclamation devoted to the American Heart Month 2004. President encouraged all Americans to join the fight against heart disease and to learn more about how to prevent it".

Joining this fight, Biosignetics Corporation (www.bsignetics.com), the worlds leading provider of biosignature and dynamic energy signature analysis software and consulting services, announces the availability of BSignal 1.0. This first commercial release of the software brings many new possibilities in the sound based characterization of auscultatory documented human heart conditions (stenosis, regurgitation, splits, clicks, gallops, snaps, rumble, valve prolapse, murmurs, septal defect, patent ductus arteriosus, atrial septal defect).

BSignal incorporates a newly developed revolutionary technology to establish unique dynamic Heart Energy Signature (HES) and to track its evolution over time. This software allows converting complex multi-component non-gaussian heart sounds into simple and self-referencing X-ray-like images.

http://www.bsignetics.com/photo_galleryAortic.htm

HES has a great potential to become de-facto standard to record, store, compare and track sound based heart diagnosis data. It can be especially effective in heart disease related research and in educating medical students and doctors to perform auscultation more effectively.

Present release incorporates user-friendly GUI with the powerful signal simulation tools that include signal processing filters, data reduction techniques with wavelets, spectrum, joint time frequency transformation, image manipulation techniques and the database of various heart sounds.

Availability
BSignal is available for PC windows NT, Win2000 and XP platforms. It is available in several versions.

http://www.bsignetics.com/products.htm

Light version BSignal - Phonocardiograph is a Class I medical device. It is presently available only in educational versions; clinical release is scheduled for Fall 2004. Full-featured BSignal -- Heart Energy Signature version is only presently available for educational purposes and for non-clinical research applications.

It can also be effectively utilized in other non-clinical applications such as brain fingerprinting" and various analyses related to EEG and brain wave interpretations. Special version of BSignal--MHM is available for machine health monitoring and diagnosis, helicopter gearboxes, and joint-time frequency domain based signal processing. It contains set of specialized criteria for automatic mechanical failure detection.

References:
1. American Heart Month 2004, By the President of the United States of America, A Proclamation    

http://www.whitehouse.gov/news/releases/2004/02/20040202-8.html

ABOUT BIOSIGNETICS
Our company's philosophy is that early detection requires instant availability of testing tools, intrinsic ability to detect weak signs of silent diseases, safety and simplicity of interpretations.

Biosignetics has developed and commercialized patent pending Heart Energy Signature format and method. Company continues its research and regulatory efforts to prepare 510(K) FDA application for clinical diagnosis version. Biosignetics is aggressively engaged in early detection research focusing on reliable detection of weak multi-component signals and patterns in otherwise noisy environment and is actively looking for clinical research partners in the medical community.

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Vladimir Kudriavtsev
BIOSIGNETICS CORPORATION
416-497-2356
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.